Frantzeska Frantzeskaki

Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia

Alex P. Betrosian, Frantzeska Frantzeskaki, Anna Xanthaki et al. · Journal of Infection · 2008 · 223 citations

High-dose Ampicillin/sulbactam, Antimicrobial Susceptibility, Health Sciences +9

High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii

Alex P. Betrosian, Frantzeska Frantzeskaki, Anna Xanthaki et al. · Scandinavian Journal of Infectious Diseases · 2007 · 132 citations

Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: Incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers

Frantzeska Frantzeskaki, Eirini‐Sofia Karampi, Christine Kottaridi et al. · Journal of Critical Care · 2014 · 88 citations

Organ Dysfunction, Viral Persistence, Immunology +8

Population Pharmacokinetics of Fosfomycin in Critically Ill Patients

Suzanne L. Parker, Frantzeska Frantzeskaki, Steven C. Wallis et al. · Antimicrobial Agents and Chemotherapy · 2015 · 77 citations · Full text

Pharmacokinetic Modeling, Intravenous Fosfomycin Treatment, Fosfomycin Clearance +9

Thrombocytopenia in critically ill patients with severe sepsis/septic shock: Prognostic value and association with a distinct serum cytokine profile

Panagiotis Tsirigotis, Spiros Chondropoulos, Frantzeska Frantzeskaki et al. · Journal of Critical Care · 2015 · 63 citations

Inflammation, Thrombosis, Ill Patients +11